
|Articles|November 1, 2003
Sight preserved in AMD patients receiving steroid derivative
New York-More drugs are in the pipeline that may have a positive impact on the treatment of patients with age-related macular degeneration (AMD). One that is providing good results is anecortave acetate (15 mg) for depot suspension, (Retaane, Alcon).
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Dr. Mali’s top 5 predictions in ophthalmology for 2026
2
FDA clears Novaliq’s Investigational New Drug application for NOV05
3
Eye exams could enable earlier detection of systemic disease
4
Low-dose pilocarpine shrinks pupil without altering accommodation in presbyopia
5



























